India has one of the world's highest fungal disease burdens, with an estimated 50 crore people affected, yet lacks dedicated institutes and expertise comparable to those for viral or bacterial infections. Diagnostic challenges include slow culture-based methods, expensive advanced equipment like MALDI-TOF (Rs 1.5 crore), and PCR tests unsuitable for fungi due to tough fungal cell walls requiring specialized extraction.
The Hindu
· May 19, 2026
· health
· 7 min read
High
Sourcing: Verified
India Lacks Expertise and Tools to Combat Rising Fungal Disease Burden
Millions of Indians suffer from fungal infections affecting eyes, skin, lungs, brain, and causing blood infections, with mucormycosis prevalence 80 times higher in India than developed countries, causing significant morbidity and mortality.
◉
Health & Medicine
8293 related articles
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% match
Climate, ecology and urbanization create perfect storm for zoonotic di…
news.cgtn.com · 99% match
Hantavirus Genome Stable as US Cruise Patient Cleared of Infection
NDTV Profit · 99% match
Greater Weight Loss From GLP-1 Drugs Significantly Reduces Obesity-Rel…
News-Medical · 99% match
Researchers call for clinical trials of Paxlovid for long COVID
Reuters · 99% match
Related Coverage
7NEWS · Aug 23
Model's Foot Cut Led to Heart Surgery, Baby Loss—Now Advocating for Better Diagnostics
Australian model Leah Ramsey lost her baby after a small foot cut triggered a rare heart infection that was repeatedly m…
Informanté · Aug 23 South Africa Shares FMD Vaccines as Region Strengthens Disease ControlsSouth Africa reports its largest-ever FMD outbreak is coming under control through accelerated vaccination and regional …
Al Jazeera · Aug 23 Solar telemedicine kiosks expand healthcare access across rural ChadSolar-powered telemedicine kiosks in rural Chad enable remote doctor consultations at a fraction of traditional travel c…
Inquirer.net · Aug 23 Prince Harry returns to UK amid family rifts, seeking reconciliation with monarchyPrince Harry and Meghan Markle are relocating back to Britain after six years in California, potentially signaling recon…
Bias & Framing
⚖
Article presents India's fungal disease crisis as a systemic failure, emphasizing lack of expertise and infrastructure while centering patient vulnerability and WHO concerns.
Bias Direction
center-left
Confidence
MED
Problem-focused narrative using personal anecdote (Sunita) to humanize the issue, combined with expert testimony and WHO authority to establish credibility. Frames fungal diseases as a neglected public health crisis requiring systemic intervention.
severe shortage
massive fungal disease burden
lacking proper training
paucity of institutes
public fears about antimicrobial resistance
miraculously
embarrassed
anxious
Government health ministry response or defense of current resource allocation
Pharmaceutical industry perspective on antifungal drug development
Cost-benefit analysis of establishing dedicated fungal disease institutes
Success stories or improvements in fungal disease management
Perspectives from private healthcare sector addressing fungal infections
Alternative or traditional treatment approaches used in India
Geopolitical Impact
🌎
India's inadequate fungal disease infrastructure poses regional health security risks, potentially creating disease reservoirs affecting South Asian neighbors and complicating global antimicrobial resistance efforts.
Escalation Risk
moderate
Confidence
HIGH
India
South Asia (Bangladesh, Sri Lanka, Nepal)
Southeast Asia
Global health systems
Highlights India's vulnerability in health infrastructure despite economic growth; creates dependency on Western pharmaceutical expertise and diagnostic technology; reduces India's soft power in global health leadership; strengthens WHO's influence in setting health priorities for developing nations.
Similar to India's initial tuberculosis crisis management gap (1990s-2000s) before establishing dedicated TB research institutes; mirrors current global antimicrobial resistance crisis where capacity gaps in developing nations undermine international containment efforts.
Economic Lens
📈
India's healthcare system faces critical gaps in fungal disease management affecting 50M people, creating opportunities for diagnostic/pharmaceutical sectors but signaling systemic healthcare infrastructure deficiencies.
Market Signal
mixed
Confidence
HIGH
Healthcare and Medical Services
Pharmaceutical and Diagnostics
Medical Device Manufacturing
Public Health Infrastructure
Medical Education and Training
Consumers face delayed diagnoses, ineffective treatments, and increased out-of-pocket spending on self-medication; quality of life impacts from untreated infections; potential for antimicrobial resistance increasing future healthcare costs.
Government should prioritize fungal disease research funding, establish dedicated mycology institutes, mandate clinical training in fungal diagnostics, incentivize diagnostic tool development, and strengthen surveillance systems similar to TB/viral disease frameworks.